Decoding clinical and molecular pathways of liver dysfunction in Psoriatic Arthritis: Impact of cumulative methotrexate doses

Decoding clinical and molecular pathways of liver dysfunction in Psoriatic Arthritis: Impact of cumulative methotrexate doses

Background: The occurrence of liver abnormalities in Psoriatic Arthritis (PsA) has gained significant recognition. Identifying key factors at the clinical and molecular level can help to detect high-risk patients for non-alcoholic fatty liver disease in PsA. Objectives: to investigate the influence...

Full description

Bibliographic Details
Main Authors: M. Ruiz-Ponce, L. Cuesta-López, M.D. López-Montilla, C. Pérez-Sánchez, P. Ortiz-Buitrago, A. Barranco, M.D. Gahete, N. Herman-Sánchez, A.J. Lucendo, P. Navarro, Ch López-Pedrera, A. Escudero-Contreras, E. Collantes-Estévez, C. López-Medina, I. Arias-de la Rosa, N. Barbarroja
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Liver disease risk
Psoriatic arthritis
Methotrexate
Phosphodiesterase 4 inhibitors
Janus kinase inhibitors
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223015779

Internet

http://www.sciencedirect.com/science/article/pii/S0753332223015779

Similar Items